Execs On The Move: Change At Codiak Biosciences, And On Qualigen, Sectra AB Boards
A new executive VP and head of research and development is joining the management team at Codiak Biosciences. In addition, new directors joined at Qualigen and Sectra AB.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.